Obinutuzumab Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 25 mg/mL
Reference Brands: Gazyva (USA), Gazyvaro (EU/UK)
Category: Oncology Cancer Care
Obinutuzumab is a humanized, glycoengineered monoclonal antibody targeting the CD20 antigen on B-cells. It is used alongside chemotherapy for conditions such as chronic lymphocytic leukaemia (CLL) and follicular lymphoma (FL) to enhance B-cell destruction via immune mediated mechanisms. Obinutuzumab is available in Injection and strengths such as 25 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Obinutuzumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Obinutuzumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Obinutuzumab is used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and follicular lymphoma. It works by targeting the CD20 protein found on the surface of B-lymphocytes, helping the immune system destroy these cancerous cells.
Obinutuzumab is a humanized monoclonal antibody produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells. It specifically binds to the CD20 antigen on B-cells, leading to their destruction.
The trade name of Obinutuzumab is Gazyva in the United States and Gazyvaro in the European Union and the United Kingdom.
Obinutuzumab (Gazyva/Gazyvaro) is developed and manufactured by Genentech, a member of the Roche Group.
The generic name is Obinutuzumab.
The brand names are Gazyva and Gazyvaro.
Obinutuzumab is manufactured by Roche and Genentech at facilities in Switzerland, Germany, and the United States under stringent biologic production standards.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
